Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Eugène T, Pallardy A, Frampas E, Carlier T, Ferrer L, Gaschet J, Davodeau F, Gestin JF, Faivre-Chauvet A, Barbet J, Chérel M. Kraeber-Bodéré F, et al. Among authors: barbet j. Semin Oncol. 2014 Oct;41(5):613-22. doi: 10.1053/j.seminoncol.2014.07.004. Epub 2014 Jul 22. Semin Oncol. 2014. PMID: 25440606 Review.
[Radiolabeled antibodies for cancer treatment].
Barbet J, Chatal JF, Kraeber-Bodéré F. Barbet J, et al. Med Sci (Paris). 2009 Dec;25(12):1039-45. doi: 10.1051/medsci/200925121039. Med Sci (Paris). 2009. PMID: 20035676 Free article. Review. French.
Radiolabeled antibodies for cancer imaging and therapy.
Barbet J, Bardiès M, Bourgeois M, Chatal JF, Chérel M, Davodeau F, Faivre-Chauvet A, Gestin JF, Kraeber-Bodéré F. Barbet J, et al. Methods Mol Biol. 2012;907:681-97. doi: 10.1007/978-1-61779-974-7_38. Methods Mol Biol. 2012. PMID: 22907380 Review.
Tumor immunotargeting using innovative radionuclides.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Mathieu C, Guérard F, Frampas E, Carlier T, Chouin N, Haddad F, Chatal JF, Faivre-Chauvet A, Chérel M, Barbet J. Kraeber-Bodéré F, et al. Among authors: barbet j. Int J Mol Sci. 2015 Feb 11;16(2):3932-54. doi: 10.3390/ijms16023932. Int J Mol Sci. 2015. PMID: 25679452 Free PMC article. Review.
Immuno-PET for Clinical Theranostic Approaches.
Bailly C, Cléry PF, Faivre-Chauvet A, Bourgeois M, Guérard F, Haddad F, Barbet J, Chérel M, Kraeber-Bodéré F, Carlier T, Bodet-Milin C. Bailly C, et al. Among authors: barbet j. Int J Mol Sci. 2016 Dec 28;18(1):57. doi: 10.3390/ijms18010057. Int J Mol Sci. 2016. PMID: 28036044 Free PMC article. Review.
Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
Kraeber-Bodéré F, Bodet-Milin C, Niaudet C, Saï-Maurel C, Moreau A, Faivre-Chauvet A, Thomare P, Deleris G, Estieu-Gionnet K, Bikfalvi A, Barbet J, Paris F. Kraeber-Bodéré F, et al. Among authors: barbet j. J Nucl Med. 2010 Apr;51(4):624-31. doi: 10.2967/jnumed.109.070714. J Nucl Med. 2010. PMID: 20351352 Free article.
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.
Frampas E, Maurel C, Remaud-Le Saëc P, Mauxion T, Faivre-Chauvet A, Davodeau F, Goldenberg DM, Bardiès M, Barbet J. Frampas E, et al. Among authors: barbet j. Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2153-64. doi: 10.1007/s00259-011-1903-0. Epub 2011 Aug 20. Eur J Nucl Med Mol Imaging. 2011. PMID: 21858527
Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.
Rousseau C, Ruellan AL, Bernardeau K, Kraeber-Bodéré F, Gouard S, Loussouarn D, Saï-Maurel C, Faivre-Chauvet A, Wijdenes J, Barbet J, Gaschet J, Chérel M, Davodeau F. Rousseau C, et al. Among authors: barbet j. EJNMMI Res. 2011 Sep 1;1(1):20. doi: 10.1186/2191-219X-1-20. EJNMMI Res. 2011. PMID: 22214534 Free PMC article.
321 results